Cancer

AACR on Campus Taiwan: A New Perspective on Cancer Research | Blog

As a PhD student at the National Taiwan University College of Medicine, Chi-Ya Shen says most of her exposure to the international cancer...

What Is Smoldering Myeloma? | Blog

Learn about smoldering myeloma and the first treatment approved by the U.S. Food and Drug Administration to prevent its progression to active multiple...

Capturing China’s Growing Scientific Momentum in AACR Journals | Blog

By Robert Kruger, PhD, Senior Executive Editor, Cancer Discovery and Editorial director of AACR’s Publishing Division, and Elizabeth S. McKenna,...

Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras | Blog

A tumor is like a strange fortress, hidden in thick fog and surrounded by moats and convoluted ramparts—an...

Cancer Risk Estimates: What Do Those Numbers Mean? | Blog

Every so often you may come across a news headline about how much something impacts your risk of...

The Tale of Tregs Told by Nobel Laureate Fred Ramsdell | Blog

Nobel laureate Fred Ramsdell, PhD, helped reveal that FOXP3 is the master switch for regulatory T cells (Tregs)—the...

Editors’ Picks: FDA’s Accelerated Approval Pathway and More | Blog

Olympic athletes are focused on accelerated movement, metabolism, and fighting (wind) resistance. So, too, are cancer researchers. This...

AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here | Blog

The second annual AACR Immuno-Oncology Conference (AACR IO), whose theme is “Discovery and Innovation in Cancer Immunology: Revolutionizing...